TG Therapeutics Inc’s filing revealed that its Director Lonial Sagar unloaded Company’s shares for reported $79675.0 on Mar 13 ’24. In the deal valued at $15.94 per share,5,000 shares were sold. As a result of this transaction, Lonial Sagar now holds 108,878 shares worth roughly $1.53 million.
Then, Charney Laurence N sold 22,000 shares, generating $351,340 in total proceeds. Upon selling the shares at $15.97, the Director now owns 215,229 shares.
Before that, Charney Laurence N sold 17,500 shares. TG Therapeutics Inc shares valued at $333,025 were divested by the Director at a price of $19.03 per share. As a result of the transaction, Charney Laurence N now holds 237,229 shares, worth roughly $3.34 million.
Goldman upgraded its TG Therapeutics Inc [TGTX] rating to a Neutral from a a Sell in a research note published on August 02, 2023; the price target was decreased to $12 from $16. BofA Securities began covering TGTX with “an Underperform” recommendation on May 20, 2022. B. Riley Securities maintained its rating on February 23, 2022. It rated TGTX as “a Buy”.
Price Performance Review of TGTX
On Monday, TG Therapeutics Inc [NASDAQ:TGTX] saw its stock fall -0.64% to $14.07. Over the last five days, the stock has lost -6.01%. TG Therapeutics Inc shares have fallen nearly -17.62% since the year began. Nevertheless, the stocks have fallen -30.17% over the past one year. While a 52-week high of $35.67 was reached on 01/10/24, a 52-week low of $6.46 was recorded on 02/21/24. SMA at 50 days reached $15.24, while 200 days put it at $13.96. A total of 2.27 million shares were traded, compared to the trading of 3.88 million shares in the previous session.
Levels Of Support And Resistance For TGTX Stock
The 24-hour chart illustrates a support level at 13.82, which if violated will result in even more drops to 13.57. On the upside, there is a resistance level at 14.45. A further resistance level may holdings at 14.83. The Relative Strength Index (RSI) on the 14-day chart is 37.02, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.43, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 92.31%. Stochastics %K at 18.88% indicates the stock is a buying.
